Wilfred A. Jefferies
Founder bei MYND LIFE SCIENCES INC.
Vermögen: 217 152 $ am Heute
Profil
Wilfred A.
Jefferies is the founder of Nevis Brands, Inc. (founded in 2011) and MYND Life Sciences, Inc. (founded in 2018) where he holds the title of Chief Science Officer.
Dr. Jefferies is also the founder of Synapse Technologies, Inc., Eyam Vaccines & Immunotherapeutics Ltd...
Dr. Jefferies's current job(s) include Chairman & Chief Scientific Officer at CAVA Healthcare, Inc., and Professor at the University of British Columbia and Michael Smith Laboratories.
Dr. Jefferies's former job includes Chairman & Chief Scientific Officer at Marker Therapeutics, Inc. Dr. Jefferies's education history includes an undergraduate degree from the University of Victoria and a doctorate degree from the Sir William Dunn School of Pathology.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MYND LIFE SCIENCES INC
21,63% | 02.02.2023 | 10 340 583 ( 21,63% ) | 217 152 $ | 31.03.2024 |
inf% | 18.10.2023 | 9 176 683 ( inf% ) | - $ | Heute |
Aktive Positionen von Wilfred A. Jefferies
| Unternehmen | Position | Beginn |
|---|---|---|
| MYND LIFE SCIENCES INC. | Founder | 06.07.2018 |
| University of British Columbia | Corporate Officer/Principal | - |
Michael Smith Laboratories
 Michael Smith Laboratories Miscellaneous Commercial ServicesCommercial Services Michael Smith Laboratories provides biotechnology research and training services. It investigates genetics in human, animals and plants, fermentation, bioprocess engineering and bioinformatics. The company is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - |
CAVA Healthcare, Inc.
 CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada. | Chairman | - |
| Eyam Vaccines & Immunotherapeutics Ltd. | Founder | - |
Ehemalige bekannte Positionen von Wilfred A. Jefferies
| Unternehmen | Position | Ende |
|---|---|---|
| NEVIS BRANDS INC. | Founder | - |
Synapse Technologies, Inc.
 Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Synapse Technologies Inc. develops an Alzheimer's diagnostic test and potential blood/brain drug delivery mechanism based on the p97 protein. | Founder | - |
| MARKER THERAPEUTICS, INC. | Chairman | 31.08.2009 |
Ausbildung von Wilfred A. Jefferies
| University of Victoria | Undergraduate Degree |
| Sir William Dunn School of Pathology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MARKER THERAPEUTICS, INC. | Health Technology |
| NEVIS BRANDS INC. | Health Technology |
| MYND LIFE SCIENCES INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
CAVA Healthcare, Inc.
CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada. | Consumer Non-Durables |
Synapse Technologies, Inc.
Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Synapse Technologies Inc. develops an Alzheimer's diagnostic test and potential blood/brain drug delivery mechanism based on the p97 protein. | Health Technology |
Michael Smith Laboratories
Michael Smith Laboratories Miscellaneous Commercial ServicesCommercial Services Michael Smith Laboratories provides biotechnology research and training services. It investigates genetics in human, animals and plants, fermentation, bioprocess engineering and bioinformatics. The company is headquartered in Vancouver, Canada. | Commercial Services |
| Eyam Vaccines & Immunotherapeutics Ltd. |
